ACLARIS
LIVE

Serial Number

98161483

Owner

Aclaris Therapeutics, Inc.

Attorney

Michael A. Geller

First Use Date

Oct 31, 2018

Filing Date

Sep 1, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ACLARIS Trademark

Serial Number: 98161483 • Registration: 7635849

ACLARIS is a trademark filed by Aclaris Therapeutics, Inc. on September 1, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Aclaris Therapeutics, Inc. (34 trademarks)

640 Lee Road, Suite 200
Wayne, PA 19087

Entity Type: 03

Trademark Details

Filing Date

September 1, 2023

Registration Date

December 31, 2024

First Use Anywhere

October 31, 2018

First Use in Commerce

October 31, 2018

Published for Opposition

June 11, 2024

Goods & Services

Research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research in the field of pharmaceuticals and biotechnology

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 31, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 31, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Dec 9, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 9, 2024 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Dec 8, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 8, 2024 AITU
USE AMENDMENT FILED
Sep 27, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Sep 27, 2024 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 6, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 11, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jun 11, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 22, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 3, 2024 CNSA
ASSIGNED TO EXAMINER
Apr 30, 2024 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 2, 2023 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 2, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 2, 2023 COAR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 27, 2023 NWOS
NEW APPLICATION ENTERED
Sep 5, 2023 NWAP